Funded Startups in Newcastle
12 funded startups in newcastle — recent funding rounds, disclosed amounts, and headquarters. Updated weekly, free to browse.
Disclosed funding sizes are highly uneven. Perfuze’s $24M round on 2025-03-13 is the only disclosed amount above $10M; the next-largest disclosed amounts sit much lower ($16M for Bottlepay on 2021-02-22, then $10M for Evergen on 2022-06-22), while several 2024–2025 biotech and energy rounds cluster under $3M (e.g., Aelius Biotech at $960K on 2025-04-07; MGA Thermal at $3M on 2024-12-03).
The dates span 2020-06-18 to 2025-04-07, with the most recent concentration in early-to-mid 2025 (four rounds from 2025-01-28 through 2025-04-07). Sector presence also clusters: Biotechnology appears in 4 entries (Aelius Biotech, Perfuze, Atelerix, nesma), and Energy appears in 3 (Allegro Energy, MGA Thermal, Evergen). Geographically, multiple entries are explicitly tagged to Newcastle, Newcastle Upon Tyne, and Australia’s Newcastle, New South Wales appears repeatedly (Allegro Energy 2025-02-14; MGA Thermal 2024-12-03 and 2020-06-18; Camplify 2022-10-20; Evergen 2022-06-22).
Most recent rounds
12 shownRelated listings
Frequently asked
What are the biggest disclosed rounds in this Newcastle list, and how sharply do they stand out?
Perfuze’s $24M (2025-03-13) is the only disclosed round above $10M. The next-largest disclosed amounts are $16M (Bottlepay on 2021-02-22) and $10M (Evergen on 2022-06-22), while the remaining disclosed rounds are mostly under $5M (e.g., MGA Thermal $3M on 2024-12-03; Evergen $10M aside).
Do the rounds cluster in a particular recent time window?
Yes. Four of the 12 rows fall between 2025-01-28 and 2025-04-07 (Atelerix $930K; Allegro Energy $1M; Perfuze $24M; Aelius Biotech $960K). More broadly, the displayed range runs from 2020-06-18 (MGA Thermal) to 2025-04-07 (Aelius Biotech).
Which sectors are most represented, and what does that imply about where funding is landing?
Biotechnology is the densest cluster with 4 of 12 entries (Aelius Biotech $960K on 2025-04-07; Perfuze $24M on 2025-03-13; Atelerix $930K on 2025-01-28; nesma is undisclosed on 2024-11-14). Energy follows with 3 entries (Allegro Energy $1M on 2025-02-14; MGA Thermal $3M on 2024-12-03; Evergen $10M on 2022-06-22).
Are there meaningful data-quality gaps around amounts or round labeling?
Amounts are not always disclosed: 2 of 12 rows are “undisclosed” (nesma on 2024-11-14; iamproperty on 2023-10-24). Round stage is also frequently unknown: 8 of 12 entries show “Series Unknown” (including Aelius Biotech 2025-04-07 and Perfuze 2025-03-13), with only a few clearly labeled like Seed (CetoAI $2M on 2023-10-16; Bottlepay $16M on 2021-02-22).
Are there outlier entries by size or by geography (same-named Newcastle locations)?
Size-wise, Perfuze’s $24M (2025-03-13) is the clear high outlier among disclosed amounts, while the smallest disclosed amount is $500K for MGA Thermal on 2020-06-18. Geography-wise, “Newcastle, Newcastle Upon Tyne, United Kingdom” appears on multiple biotech/other entries (Aelius Biotech 2025-04-07; Atelerix 2025-01-28; iamproperty 2023-10-24), while “Newcastle, New South Wales, Australia” also repeats across several rows (Allegro Energy 2025-02-14; MGA Thermal 2024-12-03 and 2020-06-18; Camplify 2022-10-20; Evergen 2022-06-22).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.